April 16, 2026

Benitec Biopharma Inc. (BNTC) Stock Analysis: 77.7% Potential Upside Ignites Investor Interest

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is capturing the attention of investors with its innovative approach to genetic medicines. The company, headquartered in Hayward, California, is at..

Compass Therapeutics, Inc. (CMPX) Investor Outlook: Unveiling a 133% Potential Upside in Biotech

For investors looking to capture substantial gains in the healthcare sector, Compass Therapeutics, Inc. (NASDAQ: CMPX) presents a compelling opportunity. With a remarkable potential upside of 133.21%, this Boston-based clinical-stage..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Navigating a 170% Potential Upside with Innovative Biotechnology

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a pioneering company in the biotechnology sector, is attracting attention from investors seeking high-risk, high-reward opportunities. Specializing in the development of mRNA-based therapeutics for..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Unpacking a 49.76% Potential Upside

ZoomInfo Technologies Inc. (NASDAQ: GTM), a leading provider of go-to-market intelligence and engagement platforms, presents an intriguing opportunity for investors amid a challenging market environment. With its robust suite of..

Neuronetics, Inc. (STIM) Stock Analysis: Unpacking a 211.75% Potential Upside

For investors seeking opportunities in the healthcare sector, Neuronetics, Inc. (NASDAQ: STIM) presents a compelling case, especially given its significant potential upside. The medical device company, headquartered in Malvern, Pennsylvania,..

Yalla Group Limited (YALA) Stock Analysis: Evaluating a 31.5% Potential Upside in the MENA Social Gaming Sector

Yalla Group Limited (NYSE: YALA), a prominent name in the social networking and gaming sector in the Middle East and North Africa (MENA) region, presents a unique investment opportunity with..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Exploring a 266.50% Potential Upside in the Biotech Sector

Candel Therapeutics, Inc. (NASDAQ: CADL) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within biotechnology. As a clinical-stage biopharmaceutical company, Candel is focused on developing..

Sanara MedTech Inc. (SMTI) Stock Analysis: Unpacking a 79.91% Potential Upside

Sanara MedTech Inc. (NASDAQ: SMTI) stands at the intersection of innovation and opportunity within the healthcare sector, specifically focusing on medical instruments and supplies. With its roots firmly planted in..

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 50.6% Potential Upside for Investors

Viant Technology Inc. (NASDAQ: DSP) is carving out a prominent position in the Technology sector, specifically within the Software – Application industry, with a market capitalization of $736.09 million. Headquartered..

SoundHound AI, Inc. (SOUN) Stock Analysis: Exploring a Potential 86% Upside with Cutting-Edge Voice AI Solutions

SoundHound AI, Inc. (NASDAQ: SOUN), a leading player in the rapidly evolving voice artificial intelligence sector, offers investors a unique opportunity to tap into the burgeoning demand for conversational AI..

Alumis Inc. (ALMS) Stock Analysis: Biotechnology Breakthrough with 58.94% Upside Potential

Alumis Inc. (ALMS), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating autoimmune disorders. Headquartered in South San Francisco, California, this clinical-stage..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 112% Upside in the Online Learning Space

As the digital landscape continues to evolve, the education sector is increasingly embracing technology to enhance learning experiences. Nerdy Inc. (NRDY), a trailblazer in online education, is strategically positioned within..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 27.93% Potential Upside for Investors

In the ever-evolving realm of healthcare, Cytek Biosciences, Inc. (NASDAQ: CTKB) stands out as a promising player within the medical devices industry. With a market capitalization of $602.9 million, this..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Unlocking 140% Upside Potential in the Biotech Sector

For investors with an eye on emerging biotech opportunities, Tvardi Therapeutics, Inc. (NASDAQ: TVRD) presents a compelling case. With an intriguing 140.15% potential upside based on current analyst targets, this..

Varex Imaging Corporation (VREX) Investor Outlook: Analyzing a 56% Potential Upside for the Medical Device Maker

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, has piqued the interest of investors with its promising outlook and substantial potential upside. Despite navigating a challenging..

Canopy Growth Corporation (CGC) Investor Outlook: Exploring a 55% Potential Upside

Canopy Growth Corporation (NASDAQ: CGC), a prominent player in the cannabis and hemp industry, is capturing investor attention with its significant potential upside of 55.51%, according to analyst ratings. Despite..

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Ups and Downs of a $5.66 Billion Biotech Powerhouse

Erasca, Inc. (NASDAQ: ERAS) stands as a notable player in the biotechnology sector, particularly within the burgeoning field of precision oncology. With a strategic focus on therapies targeting RAS/MAPK pathway-driven..

UroGen Pharma Ltd. (URGN) Stock Analysis: Assessing a 67.88% Potential Upside in the Biotech Sector

UroGen Pharma Ltd. (NASDAQ: URGN) is gaining attention for its significant potential upside in the biotechnology sector, with analysts forecasting a notable 67.88% increase from its current price of $21.51..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Exploring a 185.71% Potential Upside in the Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), headquartered in Petah Tikva, Israel, is making waves in the healthcare sector, particularly within the medical devices industry, with its innovative approach to digital X-ray..

Phathom Pharmaceuticals (PHAT) Stock Analysis: A Potential 85% Upside Awaits Investors

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands out as a notable player in the biotechnology sector, with a primary focus on developing innovative treatments for gastrointestinal diseases. With a market capitalization..

Search

Funds

April 16, 2026

Search

Funds

April 16, 2026

FTSE 100

Funds